Jentashapir Journal of Health Research

Published by: Kowsar

Prevalence of Colorectal Cancers in Isfahan Province, Iran

Zahra Tolou-Ghamari ORCID 1 , *
Author Information
1 Isfahan Kidney Transplanation Research Center, Alzahra Research Centers, Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • Jentashapir Journal of Health Research: April 30, 2019, 10 (2); e92128
  • Published Online: July 22, 2019
  • Article Type: Research Article
  • Received: April 10, 2019
  • Accepted: June 23, 2019
  • DOI: 10.5812/jjhr.92128

How to Cite: Tolou-Ghamari Z. Prevalence of Colorectal Cancers in Isfahan Province, Iran, Jentashapir J Health Res. 2019 ; 10(2):e92128. doi: 10.5812/jjhr.92128.

Copyright © 2025, Jentashapir Journal of Health Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Marley AR, Nan H. Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet. 2016;7(3):105-14. [PubMed: 27766137]. [PubMed Central: PMC5069274].
  • 2. Melnitchouk N, Shabat G, Lu P, Lyu H, Scully R, Leung K, et al. Colorectal cancer in ukraine: Regional disparities and national trends in incidence, management, and mortality. J Glob Oncol. 2018;4:1-8. doi: 10.1200/JGO.18.00145. [PubMed: 30354936].
  • 3. Bosman FT. Colorectal cancer. In: Stewart BW, Wild CP, editors. World cancer report, the international agency for research on cancer. World Health Organization; 2014.
  • 4. Haggar FA, Boushey RP. Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22(4):191-7. doi: 10.1055/s-0029-1242458. [PubMed: 21037809]. [PubMed Central: PMC2796096].
  • 5. Janout V, Kollarova H. Epidemiology of colorectal cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2001;145(1):5-10. doi: 10.5507/bp.2001.001. [PubMed: 12415635].
  • 6. [No author listed] . 6 cancer of the colon and rectum (invasive) 5-year relative and period survival by race, sex, diagnosis year, age and stage at diagnosis. Seer Cancer Government; 17 May 2016.
  • 7. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108. doi: 10.3322/caac.21262. [PubMed: 25651787].
  • 8. Khuhaprema T, Srivatanakul P. Colon and rectum cancer in Thailand: An overview. Jpn J Clin Oncol. 2008;38(4):237-43. doi: 10.1093/jjco/hyn020. [PubMed: 18356191].
  • 9. Dolatkhah R, Somi MH, Bonyadi MJ, Asvadi Kermani I, Farassati F, Dastgiri S. Colorectal cancer in Iran: Molecular epidemiology and screening strategies. J Cancer Epidemiol. 2015;2015:643020. doi: 10.1155/2015/643020. [PubMed: 25685149]. [PubMed Central: PMC4312646].
  • 10. Ibrahim EM, Zeeneldin AA, El-Khodary TR, Al-Gahmi AM, Bin Sadiq BM. Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia. Saudi J Gastroenterol. 2008;14(4):178-82. doi: 10.4103/1319-3767.43275. [PubMed: 19568534]. [PubMed Central: PMC2702938].
  • 11. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101(1):3-27. doi: 10.1002/cncr.20288. [PubMed: 15221985].
  • 12. Ries L AG, Melbert D, Krapcho M. SEER cancer statistics review, 1975-2005. Bethesda, MD; 2008.
  • 13. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ. 2000;321(7264):805-8. doi: 10.1136/bmj.321.7264.805. [PubMed: 11009523]. [PubMed Central: PMC1118620].
  • 14. Mazdak H, Tolou-Ghamari Z. Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran. Arab J Urol. 2018;16(2):206-10. doi: 10.1016/j.aju.2017.11.017. [PubMed: 29892483]. [PubMed Central: PMC5992262].
  • 15. Tolou Ghamari Z. Prevalence of lung cancer in Isfahan province, Iran. J Egypt Natl Canc Inst. 2018;30(2):57-9. doi: 10.1016/j.jnci.2018.03.001. [PubMed: 29691096].
  • 16. Tolou Ghamari Z, Tadayon F, Mazdak H. Prevalence of liver cancer in Isfahan province, Iran. Indonesian J Cancer. 2018;12(2):56-9. doi: 10.33371/ijoc.v12i2.578.
  • 17. Tolou-Ghamari Z. Prevalence of breast cancer in Isfahan province, Iran. Women Health Bull. 2018;5(4). e82678. doi: 10.5812/whb.82678.
  • 18. Tolou-Ghamari Z. Prevalence of skin cancer in Isfahan province, Iran. Jentashapir J Health Res. 2018;9(2). e82743. doi: 10.5812/jjhr.82743.
  • 19. Ghamari ZT. Prevalence of stomach cancer in Isfahan province, Iran. Gulf J Oncolog. 2018;1(28):42-5. doi: 10.5812/whb.82678. [PubMed: 30344133].
  • 20. Kolligs FT. Diagnostics and epidemiology of colorectal cancer. Visc Med. 2016;32(3):158-64. doi: 10.1159/000446488. [PubMed: 27493942]. [PubMed Central: PMC4945785].
  • 21. Rafiemanesh H, Pakzad R, Abedi M, Kor Y, Moludi J, Towhidi F, et al. Colorectal cancer in Iran: Epidemiology and morphology trends. EXCLI J. 2016;15:738-44. doi: 10.17179/excli2016-346. [PubMed: 28337105]. [PubMed Central: PMC5318687].
  • 22. Potter JD, Hunter D. Colorectal cancer: Epidemiology. In: Potter JD LN, editor. Genetics of colorectal cancer. New York: Springer; 2009. p. 5-25. doi: 10.1007/978-0-387-09568-4_1.
  • 23. Meysamie A, Ghaletaki R, Haghazali M, Asgari F, Rashidi A, Khalilzadeh O, et al. Pattern of tobacco use among the Iranian adult population: Results of the national survey of risk factors of non-communicable diseases (SuRFNCD-2007). Tob Control. 2010;19(2):125-8. doi: 10.1136/tc.2009.030759. [PubMed: 20008159]. [PubMed Central: PMC2989156].
  • 24. Tolou-Ghamari Z, Shaygannejad V, Ashtari F. Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the Isfahan Kashani Hospital. Int J Prev Med. 2013;4(Suppl 2):S274-8. [PubMed: 23776737]. [PubMed Central: PMC3678231].
  • 25. Shaygannejad V, Tolou-Ghamari Z. What is the Real Fate of Vitamin D in Multiple Sclerosis? Int J Prev Med. 2013;4(Suppl 2):S159-64. [PubMed: 23776718]. [PubMed Central: PMC3678212].
  • 26. Tolou Ghamari Z, Mehavari Habibabadi J, Palizban AA. Evidence-based pharmacotherapy of epilepsy. Arch Neurosci. 2014;2(2). e18468. doi: 10.5812/archneurosci.18468.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments